ATOSSA THERAPEUTICS, INC. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q1 2021 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Atossa Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q1 2021 to Q2 2024.
  • Atossa Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending June 30, 2024 was 126M shares, a 0.7% decline year-over-year.
  • Atossa Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 126M shares, a 0.43% decline from 2022.
  • Atossa Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 127M shares, a 8.27% increase from 2021.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 126M -891K -0.7% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q1 2024 125M -1.3M -1.03% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q4 2023 126M -543K -0.43% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-01
Q3 2023 126M -831K -0.66% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 127M -1.2K 0% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 127M +110 0% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 127M +9.67M +8.27% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-01
Q3 2022 127M +86K +0.07% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 127M +5.05M +4.16% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 127M +34M +36.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 117M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-22
Q3 2021 127M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 122M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 92.6M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.